Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma (Q37163806)
Jump to navigation
Jump to search
scientific article published on 17 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma |
scientific article published on 17 May 2010 |
Statements
1 reference
Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma (English)
1 reference
William G Wierda
1 reference
William Plunkett
1 reference
Ute Hoch
1 reference
Wei-Gang Tong
1 reference
Rong Chen
1 reference
David Siegel
1 reference
Rajni Sinha
1 reference
R Donald Harvey
1 reference
Ashraf Z Badros
1 reference
Leslie Popplewell
1 reference
Steven Coutre
1 reference
Judith A Fox
1 reference
Kristi Mahadocon
1 reference
Tianling Chen
1 reference
Peggy Kegley
1 reference
17 May 2010
1 reference
1 reference
3015-3022
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference